Journal Article Summary

The article investigates the effects of sulforaphane (SF), a compound found in broccoli, on children with Autism Spectrum Disorder (ASD). This research is significant because it explores potential treatments for ASD that target metabolic and immunologic pathways, which may offer new avenues for managing the disorder. Previous studies indicated that SF could improve behavior in young men with ASD, prompting further investigation into its effects on children.

In this study, 57 children aged 3 to 12 with ASD participated in a 36-week clinical trial. They were randomly assigned to receive either SF or a placebo for the first 15 weeks, followed by an open-label phase where all participants received SF. The researchers measured various clinical outcomes, including behavior and safety, using standardized scales. While the primary outcome measure showed no significant differences between the SF and placebo groups, caregivers reported notable improvements in behavior on secondary measures, particularly on the Aberrant Behavior Checklist.

The study has limitations, including a small sample size and the potential for placebo effects, which may have influenced the results. Additionally, the variability in children's behavior over time complicates the assessment of treatment effects. Readers should consult healthcare professionals to discuss the implications of these findings and consider the safety and efficacy of SF as a treatment option for children with ASD, especially given the need for further research to confirm these results.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.

Article Cited

  1. Zimmerman Andrew W., Singh Kanwaljit, Connors Susan L., Liu Hua, Panjwani Anita A., Lee Li-Ching, Diggins Eileen, Foley Ann, et al.. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Molecular Autism 2021. DOI: 10.1186/s13229-021-00447-5. PMID: 34034808. PMCID: PMC8146218.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]